Cargando…
The novel NF-κB inhibitor IMD-0354 induces apoptosis in chronic lymphocytic leukemia
Nuclear factor-κB (NF-κB) is an important regulator of cell survival and has been shown to be constitutively active in chronic lymphocytic leukemia (CLL) cells. Recently, a novel NF-κB inhibitor, IMD-0354 (N-(3, 5-bis-trifluoromethyl-phenyl)-5-chloro-2-hydroxy-benzamide), was shown to specifically i...
Autores principales: | Kanduri, M, Tobin, G, Åleskog, A, Nilsson, K, Rosenquist, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255277/ https://www.ncbi.nlm.nih.gov/pubmed/22829125 http://dx.doi.org/10.1038/bcj.2011.9 |
Ejemplares similares
-
Selective IKK2 inhibitor IMD0354 disrupts NF-κB signaling to suppress corneal inflammation and angiogenesis
por: Lennikov, Anton, et al.
Publicado: (2018) -
The NF-κB Inhibitor, IMD-0354, Affects Immune Gene Expression, Bacterial Microbiota and Trypanosoma cruzi Infection in Rhodnius prolixus Midgut
por: Vieira, Cecilia S., et al.
Publicado: (2018) -
New Antimicrobial Bioactivity against Multidrug-Resistant Gram-Positive Bacteria of Kinase Inhibitor IMD0354
por: Escobar, Iliana E, et al.
Publicado: (2020) -
IKKβ Inhibitor IMD-0354 Attenuates Radiation Damage in Whole-body X-Irradiated Mice
por: Waga, Kengo, et al.
Publicado: (2019) -
Studies on the treatment of melanoma with folate acid conjugated dextran and lauryl alcohol loaded with IMD0354
por: Liu, Can, et al.
Publicado: (2019)